Health Industry Shake-ups: From Company Splits to Legal Battles

This material covers significant news in the healthcare industry, ranging from CVS Health's potential split to separate its retail and insurance units, Bristol Myers winning a lawsuit, Pfizer’s stake sale in Haleon, to California's lawsuit against a Catholic hospital. Other highlights include Roche's obesity drug projections, symptoms in health workers dealing with bird flu, Australia's Sigma's merger, and Grifols' investment plans.

Health news continues to dominate headlines, with CVS Health exploring options for a potential break-up of its retail and insurance units under pressure from investors, sources say.

In legal news, Bristol Myers Squibb successfully dismissed a $6.4 billion lawsuit, Pfizer announced a $3.25 billion stake sale in Haleon, and California's attorney general sued a Catholic hospital for refusing to provide an emergency abortion.

Roche projects over $3 billion in annual sales from three early-stage obesity and diabetes drug candidates, whilst four more health workers in Missouri show symptoms after contact with a bird flu patient. Additionally, Australia's Sigma reaches an 18-year high in stock prices, and Grifols plans a $402 million investment in a new industrial center.

(With inputs from agencies.)